Atrazine potentiation of arsenic trioxide-induced cytotoxicity and gene expression in human liver carcinoma cells (HepG2).

Tchounwou PB, Wilson BA, Ishaque AB, Schneider J. Atrazine potentiation of arsenic trioxide-induced cytotoxicity and gene expression in human liver carcinoma cells (HepG2). Mol Cell Biochem. 2001 Jun; 222(1-2):49-59.

View in: PubMed

subject areas

Arsenicals
Atrazine
Cell Line, Transformed
Cell Survival
Cyclic AMP Response Element-Binding Protein
Drug Synergism
Gene Expression
Gene Expression Profiling
Hepatocytes
HSP70 Heat-Shock Proteins
Humans
Liver Neoplasms
Metallothionein
Oxides
Proto-Oncogene Proteins c-fos

authors with profiles

Paul B. Tchounwou

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support